John writes about the politics of health care, and he is the author of the twice-weekly D.C. Diagnosis newsletter. You can reach John on Signal at John_Wilkerson.07. You’re reading the web edition of ...
Engineers test, validate novel method to improve pharmaceutical research and development by Steve Martin, Purdue University edited by Gaby Clark, reviewed by Andrew Zinin Editors' notes ...
WEST LAFAYETTE, Ind. — A patent-pending innovation created and validated in Purdue University’s College of Engineering could strengthen pharmaceutical research and development in the areas of batch ...
Coast Guard aviation survival technicians (ASTs) begin a shuttle run during a Rescue Swimmer Physical Training Assessment test, April 17, 2023. (Petty Officer 2nd Class Matthew West/Coast Guard) For ...
WASHINGTON (AP) — President Donald Trump on Tuesday revived the Presidential Physical Fitness Award as part of his push to return an annual physical fitness test to America's schools. Watch the ...
President Trump formally nixed former first lady Michelle Obama’s student health program and reinstated the Presidential Fitness Test to schools across the country Tuesday as part of his “Make America ...
President Trump is nixing Michelle Obama’s student health program and returning the Presidential Fitness Test to schools across the country as part of his “Make America Healthy Again” movement.
May 5 (UPI) --In honor of National Physical Fitness and Sports Month, President Donald Trump on Tuesday signed a proclamation announcing the revival of the Presidential Fitness Test, an annual ...
Purdue Pharma, the bankrupted drug manufacturer at the center of the nation’s yearslong opioid epidemic, shut down May 1. The closure is part of a $7.4 billion deal reached after Purdue and the ...
Christine Sloan is an Emmy Award-winning reporter, who covers New Jersey for CBS News New York. Sloan re-joined the station in January 2023. She also worked at CBS News New York from 2004 to 2016.
Sun Pharmaceutical Industries will acquire New Jersey-based Organon & Co in an all-cash deal that values the U.S. company at $11.75 billion. Sun Pharmaceutical will buy all outstanding shares of ...